NYSE:CNC Centene (CNC) Stock Price, News & Analysis $75.63 -0.69 (-0.90%) (As of 09/19/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Centene alerts: Email Address About Centene Stock (NYSE:CNC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Centene alerts:Sign Up Key Stats Today's Range$75.39▼$77.1750-Day Range$64.87▼$80.2152-Week Range$63.45▼$81.42Volume3.94 million shsAverage Volume3.52 million shsMarket Capitalization$40.36 billionP/E Ratio15.04Dividend YieldN/APrice Target$85.58Consensus RatingHold Company OverviewCentene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.Read More… Billionaires Are Betting Big on “Nexus” Technology (Ad)TWO firms are already on track to crack the trillion-dollar mark because of this technology. But here's the kicker: I've discovered an under-the-radar play that's currently trading for only $8.Click here for our #1 "Retirement Window" Stock >>> Centene Stock Analysis - MarketRank™See Top Rated MarketRank™ StocksOverall MarketRank™: 95th PercentileCentene scored higher than 95% of companies evaluated by MarketBeat, and ranked 64th out of 1,007 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus RatingCentene has received a consensus rating of Hold. The company's average rating score is 2.46, and is based on 6 buy ratings, 7 hold ratings, and no sell ratings.Amount of Analyst CoverageCentene has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Centene's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth7.77% Earnings GrowthEarnings for Centene are expected to grow by 7.77% in the coming year, from $6.82 to $7.35 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Centene is 15.04, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 130.24.Price to Earnings Ratio vs. SectorThe P/E ratio of Centene is 15.04, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 116.48.Price to Earnings Growth RatioCentene has a PEG Ratio of 0.99. PEG Ratios around 1 indicate that a company is correctly valued.Price to Book Value per Share RatioCentene has a P/B Ratio of 1.56. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Centene's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.94% of the float of Centene has been sold short.Short Interest Ratio / Days to CoverCentene has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Centene has recently increased by 3.58%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCentene does not currently pay a dividend.Dividend GrowthCentene does not have a long track record of dividend growth. Sustainability and ESG3.9 / 5Environmental Score-0.26 Percentage of Shares Shorted1.94% of the float of Centene has been sold short.Short Interest Ratio / Days to CoverCentene has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Centene has recently increased by 3.58%, indicating that investor sentiment is decreasing. News and Social Media1.8 / 5News Sentiment0.31 News SentimentCentene has a news sentiment score of 0.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.43 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 26 news articles for Centene this week, compared to 14 articles on an average week.Search InterestOnly 9 people have searched for CNC on MarketBeat in the last 30 days. This is a decrease of -10% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Centene insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.33% of the stock of Centene is held by insiders.Percentage Held by Institutions93.63% of the stock of Centene is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Centene's insider trading history. Receive CNC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Centene and its competitors with MarketBeat's FREE daily newsletter. Email Address CNC Stock News HeadlinesCentene Corporation: Balancing Growth Potential with Near-Term Rate Enhancement UncertaintiesSeptember 20 at 1:24 AM | markets.businessinsider.comMeridian Partners with Mae to Improve Maternal Outcomes and Reduce Disparities Across MichiganSeptember 19 at 9:00 AM | prnewswire.comHave you heard of this 5-Day Challenge yet?You'll be interested in our 5-Day Options Trading Challenge, starting September 23. So, what makes this different from every other options research you may have seen? Well, for starters... most of them want you to first BUY their service... which is usually thousands of dollars...September 20, 2024 | InvestorPlace (Ad)Q1 2025 EPS Estimates for Centene Co. (NYSE:CNC) Reduced by Zacks ResearchSeptember 19 at 8:39 AM | americanbankingnews.comProject planned on remaining land once designated for Centene's East Coast campusSeptember 17 at 11:56 AM | bizjournals.comCNC Jan 2026 105.000 putSeptember 17 at 6:55 AM | ca.finance.yahoo.comCNC Jan 2026 115.000 callSeptember 17 at 6:55 AM | ca.finance.yahoo.comDeveloper plans project on remaining land once designated for Centene campus in CharlotteSeptember 16, 2024 | bizjournals.comSee More Headlines CNC Stock Analysis - Frequently Asked Questions How have CNC shares performed this year? Centene's stock was trading at $74.21 at the start of the year. Since then, CNC stock has increased by 1.9% and is now trading at $75.63. View the best growth stocks for 2024 here. How were Centene's earnings last quarter? Centene Co. (NYSE:CNC) issued its earnings results on Friday, July, 26th. The company reported $2.42 EPS for the quarter, missing analysts' consensus estimates of $2.44 by $0.02. The firm's revenue for the quarter was up 5.9% compared to the same quarter last year. Read the conference call transcript. When did Centene's stock split? Centene shares split on the morning of Wednesday, February 6th 2019. The 2-1 split was announced on Tuesday, February 5th 2019. The newly created shares were distributed to shareholders after the market closes on Tuesday, February 5th 2019. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. Is Centene doing a stock buyback? Centene's Board of Directors initiated a stock buyback program on Friday, December 16th 2022, which allows the company to repurchase $2,000,000,000 in shares, according to EventVestor. This means that the company could buy up to 4.3% of its stock through open market purchases. Stock buyback programs are usually an indication that the company's leadership believes its shares are undervalued. Does Centene have any subsidiaries? Centene subsidiaries include these companies: Magellan Health Inc, PANTHERx Rare Pharmacy, Apixio, WellCare Health Plans, Community Medical Group, MHM, Fidelis Care, and more. Who are Centene's major shareholders? Top institutional investors of Centene include Swedbank AB (1.90%), Bank of New York Mellon Corp (1.03%), Legal & General Group Plc (0.96%) and Dimensional Fund Advisors LP (0.88%). Insiders that own company stock include Sarah London, Andrew Lynn Asher, Kenneth J Fasola, Shannon Bagley, Christopher J Coughlin, Richard A Gephardt, Theodore R Samuels II, Lori Jean Robinson, John R Roberts, Mark J Brooks, Katie Casso, David P Thomas, Christopher Koster, Michael F Neidorff, Colin A Toney, Orlando Ayala and Brent D Layton. View institutional ownership trends. How do I buy shares of Centene? Shares of CNC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Centene own? Based on aggregate information from My MarketBeat watchlists, some other companies that Centene investors own include NVIDIA (NVDA), Alibaba Group (BABA), UnitedHealth Group (UNH), Micron Technology (MU), CVS Health (CVS), Intel (INTC) and Johnson & Johnson (JNJ). Company Calendar Last Earnings7/26/2024Today9/19/2024Next Earnings (Confirmed)10/25/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Hospital & medical service plans Sub-IndustryManaged Health Care Current SymbolNYSE:CNC CUSIP15135B10 CIK1071739 Webwww.centene.com Phone(314) 725-4477Fax314-558-2428Employees67,700Year Founded1984Price Target and Rating Average Stock Price Target$85.58 High Stock Price Target$97.00 Low Stock Price Target$69.00 Potential Upside/Downside+13.2%Consensus RatingHold Rating Score (0-4)2.46 Research Coverage13 Analysts Profitability EPS (Most Recent Fiscal Year)$5.03 Trailing P/E Ratio15.04 Forward P/E Ratio11.09 P/E Growth0.99Net Income$2.70 billion Net Margins1.79% Pretax Margin2.40% Return on Equity14.45% Return on Assets4.57% Debt Debt-to-Equity Ratio0.64 Current Ratio1.17 Quick Ratio1.17 Sales & Book Value Annual Sales$157.75 billion Price / Sales0.26 Cash Flow$9.51 per share Price / Cash Flow7.95 Book Value$48.55 per share Price / Book1.56Miscellaneous Outstanding Shares533,656,000Free Float531,895,000Market Cap$40.36 billion OptionableOptionable Beta0.48 Social Links 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report This page (NYSE:CNC) was last updated on 9/20/2024 by MarketBeat.com Staff From Our PartnersAct by Friday, August 16th, to collect this 22% dividendLet's do a little math here... To double your money at a 3% rate of return, you would need around 23 years....Investors Alley | SponsoredWhy You Should NOT Trade This MarketYou'll be interested in our 5-Day Options Trading Challenge, starting September 23. So, what makes this dif...InvestorPlace | SponsoredThis Crypto Is Set to Explode in SeptemberWith thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make ...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMust-Know for Trading OptionsOptions are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a ...Unstoppable Prosperity | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centene Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Centene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.